Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > THe REaL INFeCTION

<< Previous

Bullboard Posts

Next >>

Comment by kindvalueon Apr 07, 2020 9:44pm

196 Views

Post# 30888872

RE:RE:THe REaL INFeCTION

my main point is forget covid
the other assets have value and the stock is very cheap
008 / occular - ideally the company pursues developing as occular is the best indication and Alexion really missed out by not securing - other pharmas would like to partner on this but best they do some development work then find a partner
Amp B data soon and the stock has ripped on positive data before so watch out - could be big
Alexion should just buy ICO - perhaps they were in the market today as that was good volume
but why should they pay $6M on BERT milestone and then pay royalties and still not own 008
JUST BUY ICO

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?